Thermophilic mutants of Trichoderma reesei endoglucanase I

US9410135B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9410135-B2
Application numberUS-201113822623-A
CountryUS
Kind codeB2
Filing dateAug 11, 2011
Priority dateSep 15, 2010
Publication dateAug 9, 2016
Grant dateAug 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to mutant thermostable glycosyl hydrolases family 7 enzymes, including mutant Trichoderma reesei endoglucanase I. In particular, the present disclosure relates to mutant thermostable enzymes, compositions containing the enzymes, and methods of use thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; and an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine. 2. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 3. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 4. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 5. The mutant thermostable enzyme of claim 1 , wherein the enzyme exhibits increased thermostability as compared to the wild-type enzyme after incubation at about 50° C. for about one hour. 6. The mutant thermostable enzyme of claim 1 , wherein the enzyme has a specific activity of at least about 0.5 mMole GE/μMole enzyme/hr after incubation at about 50° C. for about one hour. 7. A composition comprising the mutant thermostable enzyme of claim 1 . 8. An isolated nucleic acid encoding the mutant thermostable enzyme of claim 1 . 9. An expression vector comprising the nucleic acid of claim 8 operably linked to a regulatory sequence. 10. A host cell comprising the expression vector of claim 9 . 11. A composition comprising the host cell of claim 10 and culture medium. 12. A method of reducing the viscosity of a pretreated biomass mixture, comprising: contacting a pretreated biomass mixture having an initial viscosity with the composition of claim 7 ; and incubating the contacted biomass mixture under conditions sufficient to reduce the initial viscosity of said pretreated biomass mixture. 13. A method of converting biomass to sugars comprising contacting the biomass with the composition of claim 7 . 14. A method of hydrolyzing or degrading biomass, comprising contacting the biomass with the composition of claim 7 . 15. A method of producing a fermentation product, comprising: contacting biomass with the composition of composition of claim 7 to form a first product; and culturing the first product with one or more fermentative microorganisms or a chemical solution under conditions sufficient to produce a fermentation product. 16. The method of claim 15 , wherein the contacting is conducted at a temperature between about 50° C. and about 55° C., between about 55° C. and about 60° C., or between about 60° C. to about 70° C. 17. A method of fermenting biomass, comprising: contacting biomass with one or more fermentative microorganisms, wherein the biomass is treated by the composition of claim 7 . 18. A method of producing a fuel comprising: contacting biomass with the composition of claim 7 to yield a sugar solution; and culturing the sugar solution with a fermentative microorganism or a chemical solution under conditions sufficient to produce a fuel. 19. The method of claim 18 , wherein the contacting is conducted at a temperature between about 50° C. and about 55° C., between about 55° C. and about 60° C., or between about 60° C. to about 70° C.

Assignees

Inventors

Classifications

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • substrate containing cellulosic material · CPC title

  • Cross-Sectional Technologies · mapped topic

  • Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title

  • C12N9/2437Primary

    Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9410135B2 cover?
The present disclosure relates to mutant thermostable glycosyl hydrolases family 7 enzymes, including mutant Trichoderma reesei endoglucanase I. In particular, the present disclosure relates to mutant thermostable enzymes, compositions containing the enzymes, and methods of use thereof.
Who is the assignee on this patent?
Chokhawala Harshal Akshay, Kim Tae-Wan, Blanch Harvey W, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12N9/2437. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).